Life support patients get kidney protection trial
NCT ID NCT07438262
Summary
This study is testing whether giving amino acids (protein building blocks) through an IV drip can help prevent or reduce serious kidney injury in adults who are critically ill and on a heart-lung life support machine (ECMO). It will involve 40 patients across three hospitals, with half receiving the amino acid treatment and half receiving a placebo (saltwater) drip to compare results. The goal is to see if this approach is safe and feasible, and if it can improve kidney function in these very sick patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alfred Hospital
Melbourne, Victoria, 3004, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.